Main Article Content

Seroprevalence of parvovirus BI9 antibody in blood donors and sickle cell disease patients at Lagos university teaching hospital (LUTH): a comparative study


MC Iheanacho
SA Akanmu
B Nwogoh

Abstract

Introduction: Parvovirus B19 (PVB19) is a DNA virus transmissible by blood transfusion. It is a major cause of aplastic crisis especially in chronic haemolytic anaemic patients such as sickle cell disease patients.
Objective: The study was aimed to determine the seroprevalence of PVB19 in blood donors and sickle cell anaemia (SCA) patients and to evaluate its association with blood transfusion in SCA patients.
Methods: This is a cross sectional study conducted at the Lagos University Teaching Hospital, Lagos Nigeria. Three hundred participants, consisting of 150 voluntary blood donors and 150 sickle cell anaemia subjects were enrolled into the study. Seroprevalence of parvovirus was determined using ELISA kits for IgG and IgM anti-PVB19 antibodies by Immuno-Biological Laboratories, (IBL) inc. Minneapolis, USA. Results was analyzed with SPSS 11 software and presented in tables. Fishers Exact test, Chi-square and student T-test were used as appropriate to compare variables between both groups. P-values <0.05 were considered significant.
Results: Ninety nine (66%) blood donors were positive for anti-PVB19 IgG antibody while ninety two (61.3%) sickle cell patients were positive. Two (1.3%) blood donors were positive anti-PVB19 IgM antibodies while 8 (5.3%) SCD patients were positive for anti-PVB19 IgM antibodies. There was no significant difference in the seroprevalence of IgG and IgM antiPVB19 virus in both groups. There was no association of parvovirus seroprevalence with blood transfusion.
Conclusion: The study has shown a high seroprevalence of IgG anti-PVB19 antibodies in both blood donors and SCA patients. Therefore routine screening for parvovirus infection for donor blood is not justified. However seronegative SCA patients who require blood transfusion should have the blood screened for parvovirus to reduce the risk of associated aplastic crisis.

Key words: Seroprevalence, parvovirus B19, blood donors, sickle cell anaemia


Journal Identifiers


eISSN: 1595-689X